Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000278 · ClinicalTrials.gov registry record · Phase 2
Disulfiram for Cocaine-Alcohol Abuse - 3
A Phase 2 study of Cocaine-Related Disorders and Alcohol-Related Disorders, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Study location
NCT00000278: Completed Phase 2 study of Cocaine-Related Disorders and Alcohol-Related Disorders, sponsored by Yale University.
NCT00000278 is a Phase 2 study of Cocaine-Related Disorders and Alcohol-Related Disorders that has completed, run by Yale University. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000278, a Phase 2 study of Cocaine-Related Disorders and Alcohol-Related Disorders, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
Conditions Studied
Interventions
- DRUG Disulfiram
Study Locations (1)
Connecticut
- VA Connecticut Healthcare System - New Haven
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-09 |
| Est. Completion | 1999-08 |
| Phase | Phase 2 |
What the finished NCT00000278 record still lists
NCT00000278 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 2 conditions, with Cocaine-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Disulfiram is the first listed.
NCT00000278 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00000278 about?
NCT00000278 is a clinical study titled "Disulfiram for Cocaine-Alcohol Abuse - 3". The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
What is the current status of trial NCT00000278?
This trial is currently completed. It is a Phase 2 study. The study started on 1994-09. Estimated completion is 1999-08.
What conditions does trial NCT00000278 study?
This clinical trial studies the following conditions: Cocaine-Related Disorders, Alcohol-Related Disorders.
What interventions are being tested in trial NCT00000278?
The interventions under investigation include: Disulfiram (DRUG).
Who is sponsoring clinical trial NCT00000278?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000278 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention
COMPLETED · Phase 2
-
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 2
-
Pharmacological Modulation of Cocaine Effects - 1
COMPLETED · Phase 2
-
Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
COMPLETED · Phase 2
-
Risperidone Treatment in Dually-Diagnosed Individuals - 2
COMPLETED · Phase 2
-
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia